This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Universitaire D'angers, Université D'angers. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 14 
1 out of 55 
Years Active: 2026
Title: Guillaume Mabilleau: Inventor in Bone Disorder Research.
Introduction
Guillaume Mabilleau is an inventor based in Avrillé, France. His patent work includes research into peptide targeting of the GIP and GLP-2 receptors for treating bone disorders.
Latest Patents
Mabilleau is associated with 1 patent: “Peptide Targeting GIP and GLP-2 Receptors for Treating Bone Disorders.”
Career Highlights
His listed affiliations include Centre Hospitalier Universitaire d’Angers and Université d’Angers.
Collaborations
Mabilleau’s listed coworker is Aleksandra Mieczkowska.
Conclusion
Guillaume Mabilleau’s patent activity reflects research into peptide-based approaches to bone disorders, alongside affiliations with healthcare and university institutions in Angers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile